A Georgetown global health law expert and a medical student propose three steps to improve access to diagnostics, therapeutics, and vaccines during public health crises. The measures include expanding regulatory coordination, leveraging regional and multilateral development banks, and promoting regulatory flexibility in pandemic agreements. They argue this would reduce the reliance on a select group of national regulatory authorities and address bottlenecks seen in the COVID-19 pandemic.
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product potential addressing a target that has clinical and regulatory
